Hester Biosciences Ltd (HESTERBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Hester Biosciences Ltd reported sales of ₹77 Cr, operating profit of ₹23 Cr (OPM 29%) and net profit of ₹97 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
HESTERBIO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 84 63 82 84 71 77 100 77 Expenses 65 58 63 61 59 60 66 54 Operating Profit 19 5 19 23 12 18 34 23 OPM 23% 8% 23% 27% 17% 23% 34% 29% Other Income 3 9 -6 3 12 2 2 89 Interest 6 -4 6 2 2 2 5 3 Depreciation 4 4 4 4 4 4 6 7 Profit before tax 12 13 4 20 17 14 25 102 Tax 29% 15% 59% 14% 16% 31% 34% 5% Net Profit 8 11 2 17 14 9 17 97 EPS in Rs 9.64 13.71 1.52 19.33 16.99 10.31 18.78 114
HESTERBIO profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 235 266 305 311 333 326 Expenses 175 215 251 250 246 239 Operating Profit 60 51 54 62 87 87 OPM 26% 19% 18% 20% 26% 27% Other Income 14 20 15 8 19 105 Interest 4 9 20 13 11 12 Depreciation 17 21 17 17 19 22 Profit before tax 54 40 32 40 76 157 Tax 26% 30% 34% 27% 24% - Net Profit 39 28 21 29 57 137 EPS in Rs 46.22 31.3 22.21 32.31 65.41 160.08 Dividend Payout 22% 26% 27% 22% 17% -
HESTERBIO balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 9 9 9 9 9 Reserves 271 283 306 329 352 Borrowings 274 244 213 214 195 Other Liabilities 116 126 126 124 123 Total Liabilities 670 662 653 675 678 Fixed Assets 259 240 233 247 411 CWIP 149 171 183 182 9 Investments 25 30 34 37 43 Other Assets 237 221 203 209 215 Total Assets 670 662 653 675 678
HESTERBIO cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 9 24 48 65 64 Cash from Investing Activity -117 -77 -22 -20 -18 Cash from Financing Activity 112 42 -26 -52 -49 Net Cash Flow 3 -12 0 -7 -3 Free Cash Flow -87 -54 24 44 47 CFO/OP 43% 63% 112% 123% 90%
HESTERBIO ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 86 109 94 86 105 Inventory Days 424 399 288 291 323 Days Payable 101 141 98 122 110 Cash Conversion Cycle 409 367 284 255 318 Working Capital Days 113 88 112 74 54 ROCE 14% 9% 9% 10% 15%